1,2-di-O-arachidonoyl-sn-glycero-3-phosphocholine

Metabolite details

Identifier

LZLVZIFMYXDKCN-QJWFYWCHSA-N

InChI Key

LZLVZIFMYXDKCN-QJWFYWCHSA-N

IUPAC name

(7R,14Z,17Z,20Z,23Z)-4-hydroxy-7-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyloxy]-N,N,N-trimethyl-10-oxo-3,5,9-trioxa-4-phosphanonacosa-14,17,20,23-tetraen-1-aminium 4-oxide

Preferred name

1,2-di-O-arachidonoyl-sn-glycero-3-phosphocholine

INN name

—

Synonym

1,2-Diarachidonylphosphatidylcholine

ChEBI

CHEBI:60657

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Global analysis of plasma lipidomics reveals altered lipid signatures in patients with osteonecrosis of the femoral head
• Metabolic profilings of rat INS-1 β-cells under changing levels of essential amino acids
• Novel Potential Diagnostic Serum Biomarkers of Metabolomics in Osteoarticular Tuberculosis Patients: A Preliminary Study
• Sexual dimorphism in the fetal cardiac response to maternal nutrient restriction.
• Absolute quantitative lipidomics reveals lipidome-wide alterations in aging brain (Mouse brain NEG UPLC-MS assay)
• 4-Octyl itaconate as a metabolite derivative inhibits inflammation via alkylation of STING

Observed in differential profiles

• Control_vs_AONFH_Stage_III_IV
• G1_Control_vs_G2_Arginine_Addition
• Healthy_Control_vs_Osteoarticular_Tuberculosis
• Control_Female_vs_Restricted_Female
• 4_weeks_vs_52_weeks
• Control_vs_DMXAA16h